3 ms·
You're right, it may not have had that result. But I think if the pharmaceutical companies had potentially significant results there would be a strong financial
by ineedasername 8y ago
You're right, it may not have had that result. But I think if the pharmaceutical companies had potentially significant results there would be a strong financial incentive to follow up with a another targeted study. It would be interesting to test, look and see whether the average number of trials per unit of time, probably year, increase after this change was made. I'm curious, but not enough to actually do the work :) Always more interesting question out there than time to follow up on them.